Highlights Thyrocare Technologies Limited NSE India S.E.

Stocks

THYROCARE

INE594H01019

Healthcare Facilities & Services

Delayed NSE India S.E. Other stock markets 04:35:09 18/06/2026 pm IST			5-day change	1st Jan Change
534.40 ^INR	+0.17%		+2.89%	+19.90%

12/05	Thyrocare Technologies Limited, Q4 2026 Earnings Call, May 12, 2026
08/05	Renewed Mideast hostilities drag Indian shares to trim weekly gain	RE

Highlights

07/05	Thyrocare Technologies Limited Recommends Final Dividend for the Financial Year 2025- 2026, Payable on July 29, 2026	CI
07/05	Thyrocare Technologies posts March-qtr consol net profit 471.2 million rupees	RE
07/05	Thyrocare Technologies Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI
29/04	Thyrocare Technologies Board to Consider Third Interim Dividend for Fiscal 2025	MT
17/03	India's Neuberg Diagnostics planning IPO within six months, says managing director	RE
28/01	Thyrocare Technologies Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
14/25/14	Thyrocare Technologies Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI
14/25/14	Thyrocare Technologies board approves bonus shares issuance in 2:1 ratio	RE
14/25/14	Thyrocare Technologies Limited Declares an Interim Dividend	CI
23/25/23	Thyrocare Technologies Limited Reports Earnings Results for the First Quarter Ended June 30, 2025	CI
23/25/23	Thyrocare Technologies Limited Recommends Final Dividend for the Financial Year 2024-25	CI
23/25/23	Thyrocare Technologies March-Quarter Consol Net Profit 217 Mln Rupees	RE
23/25/23	Thyrocare Technologies Limited Reports Earnings Results for the Full Year Ended March 31, 2025	CI
23/25/23	Thyrocare Technologies Limited Announces Company Secretary and Compliance Officer Changes, Effect from January 31, 2025	CI
23/25/23	Thyrocare Technologies Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024	CI
04/24/04	Thyrocare Technologies Makes Additional $100,000 Investment in Tanzanian JV	MT
23/24/23	Thyrocare Technologies Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024	CI
11/24/11	Thyrocare Technologies Limited completed the acquisition of Diagnostics and and pathological services business of Virnta Labs Limited from Vimta Labs Limited for INR 70 million.	CI
18/24/18	Thyrocare Technologies Reportedly Explores Divesting Radiology Business	CI
30/24/30	Thyrocare Technologies Limited entered into Business Transfer Agreement to acquire Diagnostics and and pathological services business of Virnta Labs Limited from Vimta Labs Limited for INR 70 million.	CI
27/24/27	Thyrocare Technologies Limited Approves Dividend for the Financial Year 2023-24	CI
01/24/01	Thyrocare Technologies Limited Recommends Dividend for the Financial Year 2023-24, Payable on or Before September 20, 2024	CI
29/24/29	Thyrocare Technologies Limited acquired Diagnostic and pathological services business of Polo Labs Private Limited for INR 42.6 million.	CI
23/24/23	Thyrocare Technologies Limited Reports Earnings Results for the First Quarter Ended June 30, 2024	CI
03/24/03	Thyrocare Technologies to Acquire Polo Labs' Diagnostic and Pathological Services	MT